What Do Toxicologists Do?

Slides:



Advertisements
Similar presentations
Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Advertisements

Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Carcinogen Classification Criteria Patricia Richter Ph.D., DABT Tobacco Products Scientific Advisory Committee June 8, 2010.
1 David Loschke18 March 2005 New Zealand Timber Preservation Council Annual Conference 2005 The Australian Pesticides & Veterinary Medicines Authority.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
CORE COMPETENCIES IN CLINICAL & TRANSLATIONAL RESEARCH: The Child Health Perspective I. Clinical & Translational Research Questions: Extract information.
By: Alex & Sophie BIOCHEMIST & BIOPHYSICIST. Closely related to medical scientists, biochemists and biophysicists study living organisms at the molecular.
© 2008 Society of Toxicology Creating a safer and healthier world by advancing the science of toxicology.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
Nanotechnology in Drug Discovery- Development and Delivery
The Application of the Scientific Method: Preclinical Trials Copyright PEER.tamu.edu.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Stefan Franzén Introduction to clinical trials.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Career Opportunities in Statistics John Borkowski Montana State University Panel Discussion Pattaya Conference on Statistics Pattaya, Thailand.
TCEQ/NUATRC Air Toxics Workshop: Session V – Human Health Effects Nathan Pechacek, M.S. Toxicology Section Texas Commission on Environmental Quality
Lecture #3 Hazards and their effects. Epidemiology = The study of the distribution and causes of disease and injuries in human populations. – Epidemiologists.
The Role of Research in the Business of the Environmental Protection Agency Steven Bradbury, Director Environmental Fate & Effects Division Office of Pesticide.
Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.
Project Description: Career awareness and science enhancement activities for junior high and high school students. Junior Career Day Biotechnology October.
Stefan Franzén Introduction to clinical trials.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
INTRODUCTION TO RA.
Dr. Manfred Wentz Director, Hohenstein Institutes (USA) Head, Oeko-Tex Certification Body (USA) AAFA – Environmental Committee Meeting November 10, 2008.
Presented by the American Statistical Association.
REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,
The Accelerating Pace of Medical Development and Challenges in Evaluating Benefit and Risk Alasdair Breckenridge Medicines and Healthcare products Regulatory.
INTRODUCTION TO TOXICOLOGY SIDNEY GREEN, PH.D. DEPARTMENT OF PHARMACOLOGY COLLEGE OF MEDICINE HOWARD UNIVERISTY.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
Exploratory IND Studies
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Environmental Hazards & Human Health
Copyright © 2002 University of Maryland School of Nursing. All rights reserved. Comparison of Pharmacology and Toxicology This material was developed at.
Biomedical Research. What is Biomedical Research Biomedical research is the area of science devoted to the study of the processes of life; prevention.
Center for the Environmental Implications of Nanotechology Program Solicitation NSF Preliminary Proposal Due: December 10, 2007 National Science.
Laboratory toxicology. Toxicological methods In vitro –Cell cultures –Cell-free systems –Mechanistic In vivo (lab animals) –Acute –Subchronic –Chronic.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
The Biotech Industry and Careers Why choose a career in Biotechnology? Because you can help save lives, cure diseases, help feed the hungry, help create.
Pollution and Human Health
The New Drug Development Process (www. fda. gov/cder/handbook/develop
Assessing Risks and Benefits. Risk vs. Benefit: Tipping the Scales.
Public Health and Risk Assessment (2nd of 10 Lectures on Toxicologic Epidemiology) Michael H. Dong MPH, DrPA, PhD  readings.
Chapter 15.3 Risk Assessment 2002 WHO report: “Focusing on risks to health is the key to preventing disease and injury.” risk assessment—process of evaluating.
Michael H. Dong MPH, DrPA, PhD  readings Epidemiology and Risk Assessment (4th of 10 Lectures on Toxicologic Epidemiology)
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
1 1 EPA Nanotechnology Research Program – LCA Considerations Jeff Morris National Program Director for Nanotechnology 5 November 2009.
Identification of toxic substances, their biological effects ( 生物效应 ) and management of risk.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
E-Clinical
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
B IOMEDICAL RESEARCH METHODS Unit I Chapter 3. C HEMICAL, MECHANICAL, MATHEMATICAL AND COMPUTER SIMULATIONS Prove most useful in the preliminary research.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Clinical Trials.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Drug Discovery &Development
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Clinical Trials — A Closer Look
Risk Assessment Dec 4 -6, 2006.
Biomedical Research.
Objective 2 Biomedical Research Methods
Introduction to Risk Assessment
Presentation transcript:

What Do Toxicologists Do? Most Toxicologists work to assess and understand how chemicals affect living systems Develop mechanistic understanding of effects Ensure safer chemical products Develop safer drugs & medicines Determine risks from chemical exposures Develop treatments for chemical exposures Ensure a safe food and water supply Forensics

Toxicology is an applied science with many areas of specialization Images from Gray’s Anatomy Images from webelements.com Image from Molecular Cell Biology What is so great about toxicology is that you are specialized but diverse all at the same time!! Introduce the concept of dose w/ tetrodotoxin (fugu)

Who are Toxicologists? Toxicology involves integration of information from many different areas of expertise. People working in toxicology can also be called: Biochemists Chemists Pathologists Cancer Researchers Veterinarians Medical Doctors Cell and Molecular Biologists Engineers Mathematicians Statisticians Lab Technicians Animal Care Providers

What are major areas of specialization in toxicology? Mechanistic toxicology (basic biology and chemistry) Descriptive toxicology (testing) Regulatory toxicology (rule making and compliance) Risk assessment (modeling) Translational and clinical (applying basic research to patient care)

Mechanistic Toxicology Focuses on how Chemicals produce adverse effects Biological systems protect themselves against adverse effects Involves Cellular and Molecular Biology Chemistry, often xenobiotic metabolism Xenobiotic: a chemical that is foreign to the organism

Mechanistic Toxicology Chemical research in toxicology usually investigates metabolic transformations of drugs or potentially hazardous chemicals How persistent is a chemical in the body? Are metabolic products toxic? Do test animals exhibit the same results as humans or other species of concern?

Descriptive Toxicology Typically involves toxicity testing Broad spectrum of responses reflects toxicity Functional effects, such as immunological responses Growth inhibition Reproductive impairment Increase in cancer incidence Mortality

Descriptive Toxicology Toxicity Testing Assesses the concentration-dependent hazard a chemical may present Human health Natural populations Results typically applied to Approval of product use Regulating allowable concentrations in the environment.

Descriptive Toxicology Types of toxicity testing In vitro (test tube)—useful in detecting potential biochemical and genetic effects Use model systems (bacteria, cultured animal cells, DNA interactions) In vivo (animal)—are essential for detecting health effects Acute, chronic, multi-generation Experimental animals may be treated with high doses over a lifetime to evaluate potential to cause cancer In silico (computer-based)—biological experiments conducted by computer models; these depend on data previously collected in other experiments Completion of all toxicity tests may take five or six years and is very costly

Descriptive Toxicology Toxicity Testing Molecular and cellular studies in toxicology often supplement toxicity testing results to help ascertain chemical hazard. They often unravel complex processes that underlie an adverse response. Use of toxicants can help determine the function of proteins in complex networks.

Descriptive Toxicology What private and public sectors invest in toxicity testing that aims to protect human health? Chemical Manufacturers Pharmaceutical Industry US Federal Agencies and Programs National Toxicology Program (NTP) Environmental Protection Agency (EPA) National Institute of Environmental Health Sciences (NIEHS) Food and Drug Administration (FDA) State and Local Governmental Bodies

Regulatory Toxicology Setting rules and assuring compliance Product registration Allowable concentrations in food or environmental media Technical and legal issues may require negotiation and gathering of new information Risk and safety are estimated by total weight of evidence Toxicity evidence is the basis, but often rules are modified by political, legal considerations, as well a technical feasibility

Regulatory Toxicology Risk Assessment Is the mathematical modeling process that yields estimates for safe or allowable chemical concentrations Hazard identification Dose-response assessment Exposure characterization Identify unique effects of chemical mixtures Risk assessment Risk characterization Right to know and understand Uncertainty characterization

Translational Translational science is the application of biomedical research and drug development to efficiently use a promising drug in the right patient circumstances and assess its efficacy in the human using appropriate indicators such as biomarkers. Scientists work in multidisciplinary teams involving basic researchers, clinicians, patient care providers, regulators, and ethics boards. Basic scientists provide new tools for use in patients and for assessment of their impact, and clinical researchers make novel observations about the nature and progression of disease that can lead to further basic research.